breast neoplasms
Showing 26 - 50 of 763
Breast Tumors Trial in Roma, Rome (Single-cell RNA sequencing (scRNAseq), whole-exome sequencing (WES))
Recruiting
- Breast Neoplasms
- Single-cell RNA sequencing (scRNAseq), whole-exome sequencing (WES)
-
Roma, Italy
- +1 more
Mar 29, 2023
Breast Tumors, Breast Cancer Trial in Busan, Seoul (Breast MRI for Breast Cancer Detection)
Not yet recruiting
- Breast Neoplasms
- Breast Cancer
- Breast MRI for Breast Cancer Detection
-
Busan, BusanJin-Gu, Korea, Republic of
- +3 more
Apr 2, 2023
Breast Cancer, Breast Tumors, Surgery Trial in Jette, Genk (Patient-centered teleprehabilitation)
Recruiting
- Breast Cancer
- +2 more
- Patient-centered teleprehabilitation
-
Jette, Brussels, Belgium
- +1 more
Mar 22, 2023
Inetetamab Combined With Pyrotinib and Vinorelbine as First-line
Recruiting
- Breast Neoplasms
- Inetetamab
- +2 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincial People's Hospital
Mar 16, 2023
Triple Negative Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III Trial in Boston (Implantable Microdevice (IMD))
Not yet recruiting
- Triple Negative Breast Cancer
- +6 more
- Implantable Microdevice (IMD)
-
Boston, Massachusetts
- +1 more
Mar 8, 2023
DIEP Flap Surgery and Intraabdominal Pressure
Completed
- Intraabdominal Hypertension
- Breast Neoplasms
- DIEP flap surgery
-
Aalborg, North Jutland, DenmarkUniversity hospital Aalborg
Mar 9, 2023
Breast Tumors, Chemotherapeutic Toxicity Trial in Quebec City (Application)
Recruiting
- Breast Neoplasms
- Chemotherapeutic Toxicity
- Application
-
Quebec City, Quebec, CanadaSt-Sacrement Hospital
Feb 24, 2023
Breast Tumors, Breast Tumor Female, Cancer, Breast Trial in Montréal (Thoracic paravertebral block multiple (3) injections,
Recruiting
- Breast Neoplasms
- +3 more
- Thoracic paravertebral block multiple (3) injections
- Thoracic paravertebral block single injection
-
Montréal, Quebec, CanadaCIUSSS de l'Est de l'Île de Montréal
Feb 3, 2023
Breast Cancer, Breast Tumors Trial in Fayetteville, Little Rock (Chemovax - P10s-PADRE/ MONTANIDE™ ISA 51 VG + Doxorubicin +
Completed
- Breast Cancer
- Breast Neoplasms
- Chemovax - P10s-PADRE/ MONTANIDE™ ISA 51 VG + Doxorubicin + Cyclophosphamide + Docetaxel (or Paclitaxel)
-
Fayetteville, Arkansas
- +1 more
Jan 26, 2023
Breast Mammogram and Tissue Study
Active, not recruiting
- Breast Neoplasms
-
Burlington, VermontUniversity of Vermont
Jan 26, 2023
Breast Tumors Trial in Worldwide (KU-0059436 (AZD2281) (PARP inhibitor))
Completed
- Breast Neoplasms
- KU-0059436 (AZD2281) (PARP inhibitor)
-
West Hollywood, California
- +16 more
Jan 24, 2023
Breast Cancer, Breast Tumors, Breast Carcinoma Trial in Boston (Breast Cancer Survivor Education Program)
Not yet recruiting
- Breast Cancer
- +3 more
- Breast Cancer Survivor Education Program
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jan 17, 2023
Breast Tumors, Brain Tumors, Tumors by Site Trial (Abemaciclib, Elacestrant)
Recruiting
- Breast Neoplasms
- +7 more
-
Canton, OhioGabrail Cancer Center
Jan 24, 2023
Breast Tumors Trial in Spain (No intervention)
Recruiting
- Breast Neoplasms
- No intervention
-
Elche, Alicante, Spain
- +39 more
Jan 20, 2023
Breast Tumors, Breast Cancer Trial in Houston, Sugar Land (Paclitaxel, Docetaxel, Abraxane)
Rehabilitation on Equal Terms - The ReMig Study
Recruiting
- Breast Cancer
- Breast Neoplasms
-
Lund, SwedenLund University, Skåne university hospital, Helsingborgs sjukhus
Jan 18, 2023
Breast Tumors, Breast Cancer, HER2-positive Early Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan, Paclitaxel,
Recruiting
- Breast Neoplasms
- +2 more
- Trastuzumab Deruxtecan
- +5 more
-
Springdale, Arkansas
- +203 more
Jan 13, 2023
Breast Tumors Trial in Padova (Personalized screening protocol)
Active, not recruiting
- Breast Neoplasms
- Personalized screening protocol
-
Padova, ItalyIstituto Oncologico Veneto (IRCCS)
Dec 21, 2022
HER2 Status and pCR Rate in ER-positive Breast Cancer Receiving
Completed
- Breast Neoplasms
- NET or NCT
-
Haidian, Beijing, ChinaPeking University Cancer Hospital
Dec 30, 2022
Breast Cancer Female, Breast Tumors Trial in Ghent (PET CT)
Recruiting
- Breast Cancer Female
- Breast Neoplasms
- PET CT
-
Ghent, Oost Vlaanderen, BelgiumUniversity Hospital Ghent
Jan 3, 2023
Breast Cancer: Bringing CER to the Alliance
Completed
- Breast Neoplasms
-
Madison, WisconsinUniversity of Wisconsin-Madison School of Medicine and Public He
Dec 22, 2022
Breast Tumors, Breast Diseases, Breast Fibroadenoma Trial in Chicago (Abbreviated MRI protocol: initial experience with Dotarem®
Recruiting
- Breast Neoplasms
- +3 more
- Abbreviated MRI protocol: initial experience with Dotarem® (Gadoterate Meglumine)
-
Chicago, IllinoisUniversity of Chicago Medicine
Dec 21, 2022